Earnings dates and session timing shown here are aggregated from third-party sources, are frequently estimated, and are subject to change or confirmation by the reporting company. Nothing on this site is financial advice.
InspireMD, Inc., a medical device company, is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular disease in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.
Quotes and fundamental data are delayed and provided for informational purposes only — nothing on this page is financial advice. Figures are as reported by the company and its data providers and may be revised. Estimates reflect analyst consensus at the time of each report.
$0.83
| Quarter | EPS | Revenue | Price move | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Est | Adj | Result | GAAP | Est | Actual | Surprise | 1D Pre | On-Day | 1D Post | |
Q ended Jun 30, 2026 Reported Aug 3, 2026 | $-0.20 | $-0.17 | Beat +15.0% | $-0.17 | $1.4M | $1.8M | +28.6% | 1D Pre-3.2% | On-Day+4.8% | 1D Post+5.7% |
Q ended Mar 31, 2026 Reported May 4, 2026 | $-0.18 | $-0.16 | Beat +11.1% | $-0.16 | $2.7M | $3.4M | +25.9% | 1D Pre-2.5% | On-Day+1.7% | 1D Post-6.0% |
Q ended Dec 31, 2025 Reported Mar 18, 2026 | $-0.19 | $-0.14 | ||||||||
Dashed outlines show the analyst consensus estimate for periods where one was published. Hover or tap a bar for exact figures. Values as reported; not adjusted for splits after the report date.
| — |
| $2.6M |
| $3.1M |
| +19.2% |
| 1D Pre+9.5% |
| On-Day0.0% |
| 1D Post-4.5% |
Q ended Sep 30, 2025 Reported Nov 4, 2025 | $-0.19 | $-0.17 | Beat +10.5% | — | $1.8M | $2.5M | +38.9% | 1D Pre+3.6% | On-Day-7.2% | 1D Post-0.7% |